Biotage AB earnings
Annual earnings per share (SEK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2024 | 2024-12-31 | SEK 3.55 | SEK 3.55 | 2026-06-19T06:02:31Z |
| 2023 | 2023-12-31 | SEK 3.33 | SEK 3.34 | 2026-06-19T06:02:31Z |
Revenue & profit (SEK)
| Concept | 2024 | 2023 |
|---|---|---|
| Revenue | SEK 2.06B | SEK 1.86B |
| Profit for the year | SEK 284.0M | SEK 246.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Biotage AB's ESEF annual reports (source:
filings.xbrl.org).
Figures are in SEK, as reported. Not investment advice.